Autor(es): Teixeira, Filipa ; Silva, Ana Margarida ; Macedo, Catarina ; Estevinho, Berta ; Sut, Stefania ; Dall’Acqua, Stefano ; Delerue-Matos, Cristina ; Costa, Paulo C. ; Rodrigues, Francisca
Data: 2024
Origem: Scientific Letters
Assunto(s): Selected Oral Communication
Background: Oral mucositis (OM) is a common side effect of cancer treatments such as chemotherapy [1], being characterized by disruption of the oral mucosa integrity, inflammation, and pain [1,2]. The treatment strategies to prevent and treat OM are still unsatisfactory, leading to the search of new active compounds, particularly from natural sources, such as Actinidia arguta fruits [1]. A. arguta fruit, commonly known as kiwiberry, has been associated with different therapeutic properties and pro-healthy benefits, particularly antioxidant, anti-inflammatory and anticancer effects [3,4], due to the fruit’s outstanding content in phenolic compounds, vitamins, and organic acids [3,4]. Objective: The aim of this study was to develop buccal films with A. arguta fruit extract as active ingredient to prevent OM symptoms. Methods: The films were prepared by solvent casting employing 1% of HPMC K100 LV EP, 2.5% glycerin, and A. arguta extract as solvent, previously prepared by Ultrasound-Assisted Extraction [4]. Results: Different films parameters were assessed, namely physical features (weight: 194.8 mg; thickness: 0.37 mm; disintegration time: 15.05 min; moisture content: 10.53%; swelling capacity: 55.95%), mechanical properties (resistance to extension: 10.11 N; percent of elongation: 36.10%; Young’s modulus: 0.0034 MPa) and antioxidant/antiradical activities (TPC = 6.46 mg GAE/g film; FRAP = 49.45 µmol FSE/g film; ABTS = 3.74 mg AAE/g film; DPPH = 4.90 mg TE/g film). In vitro cell assays attested the absence of negative effects on HSC-3 and TR146 oral cell lines. Most important, the compounds release profile was assessed through in vitro cell models (TR146) and ex vivo assay with porcine mucosa coupled to LC/DAD-ESI-MS quantification. The results revealed high permeation of rutin (88.32%), quercetin-3-O-glucoside (84.95%) and catechin (79.74%). Conclusions: Overall, these results highlight the significant potential and safety of buccal films with A. arguta fruit extract to prevent OM condition.
